tbvi.eu

vakzine-manager.de

Company

http://www.vakzine-manager.de/en/page2

Our Experience–Your Success. Dr Ivana Škrnjug. Gerald P. Parzmair. Vakzine Projekt Management GmbH. Middot; Mellendorfer Str. 9 · 30625 Hannover · Germany · Telefon 49 511 169908-0 · Fax 49 511 169908-29. VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. In addition, VPM acquires promising candidates from academic research and develops them in cooperation with a pool of partners to products with a high value potential.

vakzine-manager.com

Company

http://www.vakzine-manager.com/en/page2

Our Experience–Your Success. Dr Ivana Škrnjug. Gerald P. Parzmair. Vakzine Projekt Management GmbH. Middot; Mellendorfer Str. 9 · 30625 Hannover · Germany · Telefon 49 511 169908-0 · Fax 49 511 169908-29. VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. In addition, VPM acquires promising candidates from academic research and develops them in cooperation with a pool of partners to products with a high value potential.

transvac.org

Partner institutions and organisations | www.transvac.org

http://www.transvac.org/partners

EUROPEAN NETWORK OF VACCINE RESEARCH AND DEVELOPMENT. Partner institutions and organisations. Biomedical Primate Research Centre. BPRC), The Netherlands. Helmholtz Centre for Infection Research. Vakzine Projekt Management GmbH. CVI, formerly ID-Lelystad), The Netherlands. UK Department of Health, Public Health England, Centre for Emergency Preparedness and Response. CEPR, formerly under Health Protection Agency ), UK. NIBSC, formerly under Health Protection Agency), UK. TBVI), The Netherlands.

aeras.org

Partnership Model | Aeras

http://www.aeras.org/pages/partnership-model

Major Funders and R&D Partners. The Need For New Vaccines. Healthcare Workers at Risk. The Case for Investment in R&D. Partners in the Fight. Developing Global Research Capacity. Contributing to Scientific Know-How. Rarr; Partnership Model. Some of Aeras’ partners include:. The European and Developing Countries Clinical Trials Partnership. EDCTP) provides crucial funding for TB vaccine trials and enhances clinical trial site capacity. The South African Tuberculosis Vaccine Initiative. Developing Global R...

aeras.org

Partnership Model | Aeras

http://www.aeras.org/approach

Major Funders and R&D Partners. The Need For New Vaccines. Healthcare Workers at Risk. The Case for Investment in R&D. Partners in the Fight. Developing Global Research Capacity. Contributing to Scientific Know-How. Rarr; Partnership Model. Some of Aeras’ partners include:. The European and Developing Countries Clinical Trials Partnership. EDCTP) provides crucial funding for TB vaccine trials and enhances clinical trial site capacity. The South African Tuberculosis Vaccine Initiative. Developing Global R...

vakzine-manager.org

Company

http://www.vakzine-manager.org/en/page2

Our Experience–Your Success. Dr Ivana Škrnjug. Gerald P. Parzmair. Vakzine Projekt Management GmbH. Middot; Mellendorfer Str. 9 · 30625 Hannover · Germany · Telefon 49 511 169908-0 · Fax 49 511 169908-29. VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. In addition, VPM acquires promising candidates from academic research and develops them in cooperation with a pool of partners to products with a high value potential.

humanimal.nu

Home

http://www.humanimal.nu/en

Saturday, 27 August 2016. Health Innovations for Humans and Animals. HUMANIMAL – One Health is the economic life sciences program of the province Flevoland. The Development Agency Flevoland. Started 1 August 2014 executing the program. This program is meant for innovative entrepreneurship and the interdisciplinary exchange of knowledge. This should benefit the health of both humans and animals. Read all about the Award winners of the 2nd HUMANIMAL - One Health Innovation Challenge 2015. Vouchers voor het...

transvac.org

Links | www.transvac.org

http://www.transvac.org/links-0

EUROPEAN NETWORK OF VACCINE RESEARCH AND DEVELOPMENT. Biomedical Primate Research Centre. BPRC), The Netherlands. Central Veterinary Institute (CVI) of Wageningen UR. University of Oxford, UK. European Commission - Framework Program 7. Helmholtz Centre for Infection Research. London School of Hygiene and Tropical Medicine. Max Planck Institute for Infection Biology. TBVI), The Netherlands. Health Protection Agency, Centre for Emergency Preparedness and Response. CEPR, formerly CAMR), UK.

emi-tb.org

TB Facts

http://www.emi-tb.org/index.php/auto-generate-from-title

You are here:  . In 2013, 9 million people were diagnosed with TB and 1.5 million died from it. TB is the second largest killer among infectious diseases (after HIV). TB is a common secondary infection in HIV individuals, and one of the major causes of death in AIDS. In 2013, 360,000 AIDS sufferers died from TB. TB is caused by the bacterium. About one third of the world's population carries the TB pathogen in a dormant form. Multi-drug resistant TB (MDR-TB) can arise due to incomplete treatment.